• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    RNA-targeting drug relaxes muscles in myotonic dystrophy mice

    FIERCE BIOTECH

    Arrakis Unveils Data On RNA-Targeted Drug For Myotonic Dystrophy

    BUSINESSWIRE

    Arrakis Therapeutics reduces headcount by 20%

    ENDPTS

    Arrakis Therapeutics to Present at Jefferies Healthcare Conference

    BUSINESSWIRE

    Arrakis Therapeutics to Participate in Upcoming May Investor Conferences

    BUSINESSWIRE

    Arrakis Therapeutics to Participate in Upcoming Investor Conferences

    BUSINESSWIRE

    Arrakis Tx to Present at Guggenheim Healthcare Talks Oncology Conference

    BUSINESSWIRE

    Amgen partners with Arrakis to develop drugs aimed at RNA

    BIOPHARMADIVE

    Arrakis Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference

    BUSINESSWIRE

    Big Pharma can`t get enough from drugging RNA

    ENDPTS

    Roche’s James Sabry zeroes in on a new pathway and he’s paying $135M

    ENDPTS

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.